China Pharma Holdings (CPHI) Reports Q2 Loss of $0.06
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of ($0.06), versus $0.03 reported last year. Revenue for the quarter came in at $3.5 million, versus $5.7 million reported last year.
For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agree Realty (ADC) Tops Q3 FFO by 4c
- Vascular Solutions (VASC) Tops Q3 EPS by 1c; Issues Solid Outlook
- Rambus (RMBS) Tops Q3 EPS by 3c; Issues Q4 Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!